Richard D. Verschoyle

Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.

Christopher R. Ireson, S Orr, Donald J. L. Jones et al. · PubMed · 2001 · 591 citations

Chemoprevention Strategy, Nutraceutical Ingredient, Pathology +19

Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine

Timothy H. Marczylo, Richard D. Verschoyle, Darren N. Cooke et al. · Cancer Chemotherapy and Pharmacology · 2006 · 352 citations

Pharmacology, Systemic Availability, Medicine

Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.

Sarah E. Perkins, Richard D. Verschoyle, K A Hill et al. · PubMed · 2002 · 348 citations

Oncology, Chemoprevention Strategy, Dietary Curcumin +13

Structure-activity relationships of some pyrethroids in rats

Richard D. Verschoyle, W. N. Aldridge · Archives of Toxicology · 1980 · 327 citations

Biochemistry, Structure-activity Relationships, Secondary Metabolite +3

The behavioral and neuropathologic sequelae of intoxication by trimethyltin compounds in the rat.

A. W. Brown, W. N. Aldridge, B. W. Street et al. · PubMed · 1979 · 268 citations · Full text